NDC 73153-900

BREYANZI

Lisocabtagene Maraleucel

BREYANZI is a Kit in the Cellular Therapy category. It is labeled and distributed by Juno Therapeutics, Inc.. The primary component is .

Product ID73153-900_0dc7e1de-7a6d-4931-bcc1-f82c5edf6d2b
NDC73153-900
Product TypeCellular Therapy
Proprietary NameBREYANZI
Generic NameLisocabtagene Maraleucel
Dosage FormKit
Marketing Start Date2021-02-05
Marketing CategoryBLA / BLA
Application NumberBLA125714
Labeler NameJuno Therapeutics, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73153-900-01

1 KIT in 1 CARTON (73153-900-01) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08)
Marketing Start Date2021-02-05
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [BREYANZI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BREYANZI
BREYANZI
90300948 not registered Live/Pending
JUNO THERAPEUTICS, INC.
2020-11-05
BREYANZI
BREYANZI
90300931 not registered Live/Pending
JUNO THERAPEUTICS, INC.
2020-11-05
BREYANZI
BREYANZI
88569196 not registered Live/Pending
JUNO THERAPEUTICS, INC.
2019-08-07
BREYANZI
BREYANZI
88077381 not registered Live/Pending
Celgene Corporation
2018-08-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.